1 / 47

Hallucinogens

Hallucinogens. Hallucinogens. • Hallucinogens are substances that alter sensory processing in the brain, causing perceptual disturbances, changes in thought processing, and depersonalization . Modern Day History of Hallucinogens. Vietnam War Timothy Leary Harvard professor

arleen
Download Presentation

Hallucinogens

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Hallucinogens

  2. Hallucinogens • Hallucinogens are substances that alter sensory processing in the brain, causing perceptual disturbances, changes in thought processing, and depersonalization

  3. Modern Day History of Hallucinogens • Vietnam War • Timothy Leary • Harvard professor • The Psychedelic Experience

  4. The Nature of Hallucinogens • Many drugs can exert hallucinogenic effects related to neurotransmitters: • Serotonin: LSD, psilocybin, DMT • Norepinephrine: amphetamine related, mescaline, MDMA • Acetylcholine: atropine, scopolamine • Dissociative anesthetics: PCP, ketamine

  5. Names for Hallucinogens • Psychedelic • Psychotogenic • Psychotomimetic

  6. Sensory and Psychological Effects • Altered perception. • - Synesthesia: blending of the senses. Perceptual changes. • Self-reflection • - “Make conscious the unconscious” • Loss of identity and cosmic merging • - “Mystical-spiritual aspect of the drug experience” • Aldous Huxley: Doors of Perception.

  7. LSD class drugs • LSD, mescaline, • psilocybin, DMT, bufotenine • Primarily act on Serotonin receptors • Frontal cortex and limbic system • Also act on raphe nucleus which functions to filter incoming sensory stimuli • Disrupts the sorting process • Flood of sensations and perceptions

  8. LSD-class Hallucinogens • LSD Types of Agents • These drugs cause predominantly psychedelic effects. • Of high school seniors sampled: • - 1999—12.2% had used LSD sometime during life • - 2002—8.4% had used LSD sometime during life Albert Hofmann and LSD model

  9. LSD Physical Effects • LSD Types of Agents • Physiological effects: • - Massive increase in neural activity in some brain regions • - Activates sympathetic nervous system (rise in body temperature, heart rate, and blood pressure) • - Parasympathetic nervous system (increase in salivation and nausea)

  10. LSD Timeline • About half of the substance is cleared from the body within 3 hours, and more than 90% is excreted within 24 hours. • Effects of this hallucinogen can last 2–12 hours. • Tolerance to the effects of LSD develops very quickly.

  11. Psilocybin • Psilocybin—its principal source is the Psilocybe mexicana mushroom. • It is not very common on the street. • Hallucinogenic effects produced are quite similar to LSD. • Cross-tolerance among psilocybin, LSD, mescaline. • Stimulates the autonomic nervous system, dilates the pupils, increases the body temperature

  12. Psilocybe Mushrooms • Small brown mushrooms that stain blue to the touch • Illicit cultivation but also foraged from temperate climates

  13. Psilocybe Mushrooms:Religious Use Religious use continues in Oaxaca, Mexico

  14. Dimethyltryptamine (DMT) • Dimethyltryptamine (DMT) • - A short-acting hallucinogen • - Found in seeds of certain leguminous trees and prepared synthetically. • - It is inhaled and similar action as psilocybin. • - High doses can be quite intoxicating. • - Can also cause unpleasant reactions/\.

  15. DMT…it’s as common as crabgrass… • “Canary” grass; Phalaris aquatica, P. arundinacea, P. canariensis, P. tuberosa • Desmanthus illinoensis; Prairie Bundleflower • Many other sources; mostly S. America.

  16. Phalaris (DMT source)

  17. Desmanthus illinoesis (DMT Source)

  18. Bufo Frogs… • Contains bufontinin but intoxication primarily from 5-Meo-DMT • The toad is NOT licked but glands are milked for poison

  19. Amphetamine Class • Mescaline • Synthetic amphetamine derivatives (DOM, MDA, MDMA) • Act on dopamine and serotonin

  20. Amphetamine Hallucinogens • Drugs are chemically related to amphetamines. • They have varying degrees of hallucinogenic and CNS stimulant effects. • - Release serotonin are dominated by their hallucinogenic action • - Release dopamine are dominated by their stimulant effects

  21. Amphetamine Hallucinogens • Mescaline • “Designer” amphetamines • 3,4 Methylenedioxyamphetamine (MDA) • Methylenedioxymethamphetamine • (MDMA, Ecstasy)

  22. Ephedra of the USE. trifurca, E. viridis, E. torreyana,E. nevadensis and E. californica • 100 gm dried ephedra could contain anywhere from 0 to 2.6 gm of ephedrine.

  23. Ephedra grows in the deserts of the Southwest

  24. Mescaline - Mescaline is the most active drug in peyote cactus; it induces intensified perception of colors and euphoria • - Effects include dilation of the pupils, increase in body temperature, anxiety, visual hallucinations, and alteration of body image, vomiting, muscular relaxation. • Very high doses may cause death. • - Street samples are rarely authentic.

  25. Peyote • Lophophoria williamsii contains 1.5% mescaline (b-3,4,5-trimethoxyphenethylamine) • 3mg/kg potent intoxication • Up to 8 to 10 hour duration • Continued religious use in North America • Other cacti used in South America and also…

  26. Harvesting Peyote

  27. Natural Range of Peyote

  28. The Peyote Ceremony Stewart OC. Peyote Religion. Norman, OK: University of Oklahoma Press, 1987. Aberle DF. The Peyote Religion Among the Navaho. Chicago, IL: Aldine Publishing Co., 1966.

  29. MDMA (‘Ecstasy’)

  30. Psychostimulants The most common psychostimulants (cocaine, MDMA and amphetamine) act on the synapse to increase the activity of dopamine, noradrenaline and serotonin. Cocaine blocks pre-synaptic reuptake

  31. MDMA (‘Ecstasy’) • A synthetic amphetamine derivative, usually sold as small tablets or capsules • Many tablets sold as ecstasy also contain other chemicals including: ketamine, GHB, amphetamine, caffeine. • A recent study (Baggott et al 2000) found that: • 63% contained MDMA • 29% contained other substances (e.g. caffeine, psuedoephedrine) • 8% contained no MDMA

  32. MDMA (‘Ecstasy’): Effects • Immediate sought after-effects, 4-6 hours in duration • euphoria, increased confidence, increased perception of closeness to others, visual hallucinations • Negative effects • jaw clenching, anxiety, paranoia, insomnia, dry mouth, increased body temperature

  33. Party drug culture • High levels of activity: hydration and hyperthermia • Poly-drug use, illicit and misuse of prescribed substances: • Viagra used primarily within the gay community • Anti-depressants and benzodiazepines thought to increase the ‘high’ or relieve the ‘come down’ associated with party drug use

  34. Risks of Ecstasy • Toxicity: MDMA overdose is rare • associated with intense sympathomimetic responses and active hallucinations as well as thermoregulatory, neurologic, cardiovascular, hepatic and electrolyte disturbances (Gowing et al 2002). • Risks of adulterants • Dependence syndrome (occasionally) • Some evidence of cognitive impairment as a result of long term use (Kalant, 2001) • Association between long-term MDMA use and emotional disturbance (depression).

  35. Anticholinergics • Attach to Ach receptors and act as antagonists • Found in Belladonna, Nightshade, Jimsonweed and Mandrake plants

  36. Ach Antagonists • Plants containing scopolamine • Low doses produce amnesia, fatigue, mental confusion, dreamless sleep and loss of attention • High doses: Hallucinations, paralysis of respiratory system, coma, and death. • Side Effects: increase in sympathetic activity • Hot as a hare, dry as a bone, red as a beet, and mad as a hen

  37. Datura stramonium • Leaves typically cut and smoked • Contains atropine, scopalomine • Ancient ceremonial use in the U.S. • Occasional report of death by ingestion of root • Many other sources for atropine and scopalomine • Member of Nightshade family • “Jimson weed”

  38. Dissociative Drugs Dissociative Drugs PCP (phencyclidine) Ketamine Dextromethorphan

  39. • Phencyclidine (PCP) • It was developed as an intravenous anesthetic, • but found to have serious adverse side effects. • It differs from the other traditional hallucinogens. • It is a general anesthetic in high doses. • It causes incredible strength and extreme violent behavior. • Management of the severe psychological reactions requires drug therapy.

  40. PCP physiological effects • - Hallucinogenic effects, stimulation, depression, anesthesia, analgesia • - Large doses can cause coma, convulsions, and death. • PCP psychological effects • - Feelings of strength, power, invulnerability; • perceptual distortions, paranoia, violence, • Potential for psychotic break.

  41. Ketamine (“Special K”) • Anesthetic developed to replace PCP, manufactured by Pfizer • Used in human and veterinary medicine • Injected or dried and snorted • Feelings of floating, or sometimes terrifying “bad trip” called “K hole” • “Vitamin K” • “K” • “Bump”

  42. DXM (dextromethorphan) • Cough suppressant • (Also used to boost effects of analgesics for severe pain) • Typical dose 15-30 mg. for cough • 4 or more ounces may cause distorted visual perceptions, similar effects to PCP and Ketamine • “Robo” • Internet groups to discuss “Robo-ing”

  43. Statistics on Use • National Survey on Drug Use and Health (2004 & 2005) • Monitoring the Future (National Survey) (2005) • Drug Abuse Warning Network (DAWN)

  44. NSDUH Hallucinogen Statistics Percentages of Past Year Hallucinogen Use among Persons Aged 12 or Older, by Age Group: 2004 and 2005

  45. Monitoring the Future Hallucinogens 2005

  46. Hallucinogens in ER Visits, 2005

  47. AAPCC Annual Report 2005 2005 Annual Report of the American Association of Poison Control Centers’ National Poisoning and Exposure Database. Clinical Toxicology, 44:803-932, 2006

More Related